论文部分内容阅读
慢性心衰(CHF)是常见的临床问题,预后不良。近年来使用血管扩张剂和转化酶抑制剂治疗,改善了心衰病人的后果。心脏移植戏剧性地改变了严重心衰病人的前景,但对移植的最佳时间仍有争议。需要证明处于高危的病人和预示中度到严重心衰病人的预后的重要性日益增加,因为预后是劝告病人接受移植或使用某些新药的主要考虑。本文对一组心衰病人进行回顾性研究,证实影响后果(死亡或心脏移植)的指标。
Chronic heart failure (CHF) is a common clinical problem with poor prognosis. In recent years, the use of vasodilators and invertase inhibitors to improve the outcome of heart failure patients. Cardiac transplantation has dramatically altered the outlook of patients with severe heart failure, but the optimal timing of transplantation remains controversial. The need to prove that at-risk patients and predicts the prognosis of patients with moderate to severe heart failure is on the rise, as prognosis is a major consideration in advising patients on transplant or on the use of certain new drugs. A retrospective study of a group of patients with heart failure confirms the impact of outcomes (death or heart transplant).